Virtu Financial LLC Axonics, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	SELL	$47.99 - $60.21 $304,544 - $382,092	-6,346 Reduced 54.24%	5,353 $270,000
Q1 2023 May 01, 2023	BUY	$52.6 - $67.34 $615,367 - $787,810	11,699 New	11,699 $638,000
Q4 2020 Feb 24, 2021	SELL	$42.19 - $51.5 $634,242 - $774,199	-15,033 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$35.33 - $51.04 $308,713 - $445,987	8,738 Added 138.81%	15,033 $767,000
Q2 2020 Aug 07, 2020	BUY	$22.91 - $39.83 $144,218 - $250,729	6,295 New	6,295 $221,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.